Supports clinical trials planning across the cancer prevention and control spectrum, including prevention, screening, early detection, healthcare delivery, symptom management, supportive care, and survivor outcomes. Funds preparatory studies to fill information gaps, improve trial design, test new trial designs, and enhance feasibility to reduce costs and improve trial completion.
Eligible applicants include a wide range of organizations such as public housing authorities, nonprofits, government entities, educational institutions, small businesses, tribal organizations, and other specified groups including federal agencies and foreign organizations.
